Sanofi Q3 2014 Results - Interview with Jérôme Contamine

PARIS, October 27, 2014 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2014. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and full year guidance.

Watch video interview and read transcript: 

http://www.eurobusinessmedia.com/ceo-direct/sanofi/interview-with-cfo-jerome-contamine-q3-2014-results,2014-10-27,1292?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include: 

• Growth platforms
• Vaccines
• Animal Health
• Diabetes
• Multiple sclerosis
• R&D pipeline
• Guidance

About Sanofi  

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

SOURCE Sanofi